Adivo

Adivo is a veterinary biotechnology company dedicated to developing therapeutic antibodies for pets. The focus is on treating severe diseases in dogs, with the potential to provide treatments for other species. Antibody selection is based on a new, fully synthetic, dog-specific drug library, which can be used to isolate optimal antibody properties using phage display technology. Adivo is a subsidiary of MorphoSys AG. Years of expertise in the development of human therapeutic antibodies have enabled the Adivo team to transition into veterinary medicine.